CA
PHIO icon

Cetera Advisors’s Phio Pharmaceuticals PHIO Stock Holding History

Cetera Advisors’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$20.7K Buy
+3,380
New +$23.3K ﹤0.01% 2395

Other funds holding PHIO

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cetera Advisors's PHIO Position: Q1 2024 in Review

Cetera Advisors opened a new position in Phio Pharmaceuticals (PHIO) in Q1 2024: 3,380 shares worth $20.7K. The stake represents ﹤0.01% of the portfolio and ranks #2395 among its holdings.

10 funds tracked by Wall St. Rank hold PHIO as of Q1 2024.

  • Cetera Advisors held 3,380 shares of Phio Pharmaceuticals worth $20.7K as of Q1 2024.
  • Phio Pharmaceuticals was a new Cetera Advisors position in Q1 2024.
  • Phio Pharmaceuticals made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2395 holding.
  • 10 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.